Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Sarepta Therapeutics Q1 2026 Earnings Call - ELEVIDYS Stabilization and siRNA Pipeline Acceleration
Sarepta Therapeutics reported Q1 2026 results that underscore a business stabilizing after the turbulence of 2025. Total revenue came in at $731 million, driven by $331 million in net product sales sp...
- Total revenue of $731 million in Q1 2026, a 2% year-over-year decrease, driven by lower ELEVIDYS sales partially offset by collaboration revenue.
- Net product revenue was $331 million, comprising $229 million from the PMO franchise and $102 million from ELEVIDYS.
- The company reported a GAAP operating profit of $358 million, supported by $400 million in collaboration and milestone revenue, including a $325 million non-cash item from Roche.
- +7 more takeaways
Encore Capital Group Q1 2026 Earnings Call - Record Collections and Raised Guidance Signal a Strong Credit Cycle
Encore Capital Group delivered a standout first quarter in 2026, driven by record global collections of $718 million and aggressive portfolio purchasing of $363 million. The company's U.S. debt buying...
- Record global collections surged 19% year-over-year to $718 million, driven by strong execution and operational innovation in the U.S. market.
- Global portfolio purchases reached $363 million, with 87% of capital deployed in the U.S. to capitalize on abundant supply and attractive returns.
- U.S. charge-off rates remain at their highest level in over a decade, creating a robust and stable supply environment for debt buyers.
- +7 more takeaways
Clover Health Q1 2026 Earnings Call - GAAP Profitability Hits $27M as Membership Surges 51%
Clover Health reported a decisive shift in its Medicare Advantage strategy during Q1 2026, achieving GAAP net income of $27 million while expanding membership by 51% year-over-year to 156,000 lives. T...
- GAAP net income reached $27 million, a $29 million year-over-year improvement, proving the model can scale profitability alongside rapid growth.
- Medicare Advantage membership surged 51% year-over-year, adding over 52,000 lives to reach approximately 156,000 members.
- Total revenue jumped 62% year-over-year to $749 million, reflecting both enrollment gains and favorable medical cost performance.
- +12 more takeaways
Beyond Meat Q1 2026 Earnings Call - Cash Burn Slows as Functional Beverage Pivot Begins
Beyond Meat reported Q1 2026 revenues of $58.2 million, down 15.3% year-over-year, as volume declines in U.S. retail and food service channels offset modest price increases. Gross margin improved to 3...
- Q1 2026 net revenues fell 15.3% to $58.2 million, driven by a 19.5% decline in volume sold, partially offset by a 5.4% increase in net revenue per pound.
- Gross margin improved significantly to 3.4% from a 10.1% loss year-over-year, benefiting from lower inventory provisions and reduced manufacturing expenses, though obscured by fixed cost absorption issues.
- Cash burn for the quarter was $11.8 million, the lowest quarterly cash use in over two years, reflecting successful restructuring and SG&A reductions.
- +10 more takeaways
Fortinet Q1 2026 Earnings Call - AI-Driven Security Boom Fuels Record Cash Flow and Market Share Gains
Fortinet delivered a blistering Q1 2026, shattering guidance with 31% billing growth, 20% total revenue growth, and a record $1 billion in free cash flow. The results underscore a fundamental shift in...
- Billing growth surged 31% to $2.09 billion, crushing the high end of guidance, driven by broad demand across Secure Networking (+32%) and Unified SASE (+31%).
- Total revenue rose 20% to $1.85 billion, with product revenue exploding 41% to $645 million as customers shifted toward higher-performance FortiGate appliances to handle AI traffic.
- Free cash flow hit a record $1.01 billion, underscoring the durability of Fortinet’s business model and its ability to generate cash despite heavy AI-related infrastructure investments.
- +7 more takeaways
Coherent Q3 FY2026 Earnings Call - Record Backlog and NVIDIA-Backed CPO Partnership Fuel Accelerated Growth
Coherent delivered a record $1.8 billion in Q3 FY2026 revenue, up 27% year-over-year on a pro forma basis, driven by exceptional demand across its data center and communications segments. The company’...
- Record $1.8 billion Q3 FY2026 revenue, up 27% year-over-year on a pro forma basis, with accelerating growth momentum.
- Backlog reached record levels, with orders now extending into calendar 2028 and long-term agreements (LTAs) covering demand through the end of the decade.
- Non-GAAP gross margin expanded 105 basis points year-over-year to 39.6%, driven by 6-inch indium phosphide yield improvements, cost reductions, and pricing optimization.
- +7 more takeaways
Vanda Pharmaceuticals Q1 2026 Earnings Call - NEREUS Launch and Raised 2026 Guidance Signal Transformational Year
Vanda Pharmaceuticals delivered a strong Q1 2026 quarter, driven by a 26% year-over-year jump in Fanapt sales and the commercial debut of NEREUS via a direct-to-consumer platform. Total net product sa...
- Fanapt net product sales surged 26% year-over-year to $29.6 million in Q1 2026, driven by a 32% increase in total prescriptions and a 76% jump in new-to-brand prescriptions.
- Total net product sales reached $51.7 million, a 3% increase from Q1 2025, though a 10% sequential decline reflects typical post-deductible reset headwinds.
- Full-year 2026 revenue guidance was raised to $240–290 million, incorporating $10–30 million from the newly launched NEREUS product.
- +7 more takeaways
TriplePoint Venture Growth BDC Q1 2026 Earnings Call - NII Covers Dividend Amid AI-Driven Portfolio Rotation and Strategic Buyback Launch
TriplePoint Venture Growth BDC reported Q1 2026 results that underscore a deliberate pivot away from legacy consumer debt toward AI-adjacent venture growth lending. Net investment income of $0.23 per ...
- Net investment income of $0.23 per share fully covered the $0.23 dividend, maintaining payout sustainability despite market volatility.
- Weighted average annualized portfolio yield rose to 13.5% from 12.7% in Q4, driven by a shift toward higher-yielding term loans and accelerated prepayment income.
- Gross leverage ratio declined to 1.27x from 1.33x, with unfunded commitments reduced by 20% to $207 million, reflecting a deliberate deleveraging and capital discipline strategy.
- +7 more takeaways
Ascent Industries Q1 2026 Earnings Call - Revenue Growth Masks Margin Compression, Pipeline Conversion Accelerates, and Midwest Acquisition Signals Strategic Shift
Ascent Industries reported Q1 2026 revenue of $19.4 million, up nearly 10% year-over-year, driven by strong pipeline conversion and execution rather than market tailwinds. The company won 31 projects ...
- Revenue grew 8.9% year-over-year to $19.4 million, driven by execution and pipeline conversion, not market recovery.
- Gross margin contracted 270 basis points to 14.5%, attributed to timing and absorption issues from ramping new programs, not structural cost deterioration.
- Material costs improved to $0.61 per pound from $0.71 in Q4, confirming margin pressure is operational, not raw-material driven.
- +11 more takeaways
DoubleVerify Q1 2026 Earnings Call - Social Activation Surges 92% as AI SlopStopper Drives Attach Rates
DoubleVerify delivered a solid Q1 2026 with 10% year-over-year revenue growth to $181 million and a 31% EBITDA margin, driven by a 92% jump in social activation revenue and a 23% acceleration in socia...
- Social activation revenue grew 92% year-over-year, accelerating from 62% in Q4, with Meta Activation reaching a $12 million annualized run rate and 87 advertisers onboard.
- Total Q1 2026 revenue was $181 million, up 10% year-over-year, with measurement revenue growing 16% and activation revenue growing 6%.
- EBITDA margin expanded to 31% from 27% in Q1 2025, driven by AI-powered operational efficiencies that reduced contractor labeling needs by over 100 by year-end.
- +7 more takeaways